Proving Scientific Innovation at Scale

2026 Full Event Guide

Create Targeted & Scalable Cell Therapies through In-Vivo & Ex-Vivo Innovation, Automation, & Partnerships that Expand Access to Life-Changing Treatments

Cell therapy entered a pivotal moment, with global investment and scientific innovation reshaping the landscape. While funding challenges persisted, Europe and Asia emerged as key hotspots for rapid clinical development and strategic partnerships. The rise of in‑vivo CAR‑T and next‑generation TCR approaches underscored a shift toward scalable, cost‑effective therapies that promised to transform patient access and long‑term commercial viability

Returning to London for its 9th year, the CAR-TCR Summit Europe once again served as the essential forum for cutting‑edge scientific insight, practical manufacturing strategy, and critical business intelligence required to accelerate clinical success. Attendees explored the latest advances in novel CAR and TCR designs, armouring strategies, and engineered signalling pathways, while also learning how leading institutions were improving scale, automation, and point‑of‑care solutions to reduce cost and enhance reliability.

The summit empowered participants to connect with Europe’s top companies and research centres, ensuring they remained ahead of innovation trends, strengthened manufacturing capabilities, and built the partnerships needed to drive the next generation of life‑saving cell therapies across the continent and beyond.

Download the Agenda

Very focused on the topic at hand, highly relevant presentations. It was my first CAR-T/TCR-T conference and I got what I was looking for - information AND opinions of the community.

Chief Business Officer, Captain T-Cell, 2025 Attendee

It was an incredible opportunity to hear from the world's leading developers of novel cell therapies. What stood out to me was the extremely insightful presentations and discussion panels.

Business Development Manager, Nona Biosciences, 2025 Attendee

The CAR-TCR Summit is truly unique in its depth and breadth. It brings together every aspect of the field, from basic discovery to clinical application and commercialisation. What makes it exceptional is the combination of top-tier scientists, industry leaders, and key decision-makers in one forum. It’s an invaluable opportunity to exchange insights, align standards, and collectively shape the future of cell therapy innovation.

Group Leader, Heidelberg University Hospital, 2026 Speaker